American Medical Association

SHERPA: White

People

  1. Landgren
    Landgren
  2. Hultcrantz
    Hultcrantz
  3. Korde
    Korde
  4. Mailankody
    Mailankody
  5. Rustad
    Rustad
  6. Dogan
    Dogan
  7. Lu
    Lu
  8. Maura
    Maura
  9. Ramanathan
    Ramanathan
  10. Scheinberg
    Scheinberg

Groups

  1. Center for Hematologic Malignancies (11)
  2. Department of Medicine (11)
  3. Hematologic Malignancies Research (11)
  4. Hematologic Malignancies, Division of (11)
  5. Myeloma (9)
  6. Sloan Kettering Institute Postdocs (4)
  7. Survivorship Research (4)
  8. Adult Leukemia (2)
  9. Advanced Practice Providers (2)
  10. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (2)
Search Within
  1. "Hematologic Malignancies Research"
Formats
  1. Journal Article (9)
  2. Research Letter (1)
  3. Review (1)
Groups
  1. Center for Hematologic Malignancies (11)
  2. Department of Medicine (11)
  3. Hematologic Malignancies Research (11)
  4. Hematologic Malignancies, Division of (11)
  5. Myeloma (9)
  6. Sloan Kettering Institute Postdocs (4)

More Groups

People
  1. Carl Landgren (9)
  2. Malin Hultcrantz (4)
  3. Neha Korde (4)
  4. Even Rustad (3)
  5. Sham Mailankody (3)
  6. Ahmet Dogan (2)

More People

Years
  1. 2021 (2)
  2. 2020 (1)
  3. 2019 (1)
  4. 2018 (2)
  5. 2015 (3)
  6. 2004 (1)

More Years

Publications
  1. JAMA Oncology (9)
  2. JAMA - Journal of the American Medical Association (2)

Results (11)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety and effectiveness of weekly carfilzomib, lenalidomide, dexamethasone, and daratumumab combination therapy for patients with newly diagnosed multiple myeloma the MANHATTAN nonrandomized clinical trial
    Journal Article

    Landgren, O.; Hultcrantz, M.; Diamond, B.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; Tan, C.; Shah, U. A.; Lu, S. X.; Salcedo, M.; more...
    JAMA Oncology (2021)

    Fulltext@MSK | Save
  • Assessment of discordance among smoldering multiple myeloma risk models
    Research Letter

    Hill, E.; Dew, A.; Morrison, C.; Yuan, C.; Stetler-Stevenson, M.; Landgren, O.; Kazandjian, D.
    JAMA Oncology (2021)

    Fulltext@MSK | Save
  • Moving from cancer burden to cancer genomics for smoldering myeloma: A review
    Review

    Maura, F.; Bolli, N.; Rustad, E. H.; Hultcrantz, M.; Munshi, N.; Landgren, O.
    JAMA Oncology (2020)

    Fulltext@MSK | Save
  • Association of immune marker changes with progression of monoclonal gammopathy of undetermined significance to multiple myeloma
    Journal Article

    Landgren, O.; Hofmann, J. N.; McShane, C. M.; Santo, L.; Hultcrantz, M.; Korde, N.; Mailankody, S.; Kazandjian, D.; Murata, K.; Thoren, K.; more...
    JAMA Oncology (2019)

    Fulltext@MSK | Save
  • Remission and progression-free survival in patients with newly diagnosed multiple myeloma treated with carfilzomib, lenalidomide, and dexamethasone: Five-year follow-up of a phase 2 clinical trial
    Journal Article

    Kazandjian, D.; Korde, N.; Mailankody, S.; Hill, E.; Figg, W. D.; Roschewski, M.; Landgren, O.
    JAMA Oncology (2018)

    Fulltext@MSK | Save
  • Multiple myeloma and its precursor disease among firefighters exposed to the World Trade Center disaster
    Journal Article

    Landgren, O.; Zeig-Owens, R.; Giricz, O.; Goldfarb, D.; Murata, K.; Thoren, K.; Ramanathan, L.; Hultcrantz, M.; Dogan, A.; Nwankwo, G.; more...
    JAMA Oncology (2018)

    Fulltext@MSK | Save
  • Agent Orange exposure and monoclonal gammopathy of undetermined significance: An Operation Ranch Hand veteran cohort study
    Journal Article

    Landgren, O.; Shim, Y. K.; Michalek, J.; Costello, R.; Burton, D.; Ketchum, N.; Calvo, K. R.; Caporaso, N.; Raveche, E.; Middleton, D.; more...
    JAMA Oncology (2015)

    Fulltext@MSK | Save
  • Treatment with carfilzomib-lenalidomide-dexamethasone with lenalidomide extension in patients with smoldering or newly diagnosed multiple myeloma
    Journal Article

    Korde, N.; Roschewski, M.; Zingone, A.; Kwok, M.; Manasanch, E. E.; Bhutani, M.; Tageja, N.; Kazandjian, D.; Mailankody, S.; Wu, P.; more...
    JAMA Oncology (2015)

    Fulltext@MSK | Save
  • The role of diagnosis and clinical follow-up of monoclonal gammopathy of undetermined significance on survival in multiple myeloma
    Journal Article

    Sigurdardottir, E. E.; Turesson, I.; Lund, S. H.; Lindqvist, E. K.; Mailankody, S.; Korde, N.; Björkholm, M.; Landgren, O.; Kristinsson, S. Y.
    JAMA Oncology (2015)

    Fulltext@MSK | Save
  • Clinical research in the United States at a crossroads: Proposal for a novel public-private partnership to establish a national clinical research enterprise
    Journal Article

    Crowley, W. F. Jr; Sherwood, L.; Salber, P.; Scheinberg, D.; Slavkin, H.; Tilson, H.; Reece, E. A.; Catanese, V.; Johnson, S. B.; Dobs, A.; more...
    JAMA - Journal of the American Medical Association (2004)

    Fulltext@MSK | Save